By Counterforce Health Team in Pomalyst (pomalidomide) —

Getting Pomalyst (Pomalidomide) Approved by Humana in Washington: Complete Prior Authorization and Appeals Guide

How to Get Pomalyst Approved by Humana in Washington

Quick Answer: Humana requires prior authorization for Pomalyst (pomalidomide) with documented failure of both lenalidomide and a proteasome inhibitor, plus REMS program enrollment. Submit through your oncologist with complete therapy history. If denied, use Humana's internal appeals process first—Washington's external review doesn't apply to Medicare plans. Standard approval takes 3-14 days; expedited reviews are available for urgent cases. Start by gathering your prior treatment records and confirming REMS enrollment status.

Table of Contents

  1. Patient Profile: Who Needs Pomalyst
  2. Pre-Authorization Preparation
  3. Submission Process
  4. Initial Outcome: Approval or Denial
  5. Appeals Process in Washington
  6. Resolution and Approval Terms
  7. What We'd Do Differently
  8. Templates and Checklists
  9. Frequently Asked Questions

Patient Profile: Who Needs Pomalyst

Pomalyst (pomalidomide) is prescribed for multiple myeloma patients who've already tried at least two prior therapies, including both lenalidomide (Revlimid) and a proteasome inhibitor like bortezomib or carfilzomib, with disease progression within 60 days of their last treatment.

Typical Patient Scenario:

  • Diagnosed with multiple myeloma 2-3 years ago
  • Previously treated with lenalidomide-based regimen (failed or became resistant)
  • Tried at least one proteasome inhibitor (bortezomib, carfilzomib, or ixazomib)
  • Disease has progressed despite treatment
  • Seeking next-line therapy options

The medication costs approximately $23,400 for a 21-capsule pack (one treatment cycle), making prior authorization nearly universal among insurers, including Humana Medicare Advantage and Part D plans.

Pre-Authorization Preparation

Before submitting your Pomalyst prior authorization to Humana, gather these essential documents:

Required Documentation Checklist

Medical History:

  • Complete multiple myeloma diagnosis with ICD-10 code
  • Pathology reports confirming diagnosis
  • Current staging and cytogenetics results
  • Recent lab values (CBC, comprehensive metabolic panel, M-protein levels)

Prior Treatment Records:

  • Timeline of all previous therapies with start/stop dates
  • Documentation of lenalidomide failure or intolerance
  • Evidence of proteasome inhibitor trial and progression
  • Reason for discontinuation of each prior therapy
  • Disease progression documentation within 60 days of last treatment

REMS Program Requirements:

  • Prescriber REMS certification confirmation
  • Patient REMS enrollment and signed agreement
  • Pharmacy REMS certification (if known)
  • Pregnancy testing results (for women of childbearing potential)
  • Contraception counseling documentation
Tip: The PS-Pomalidomide REMS program enrollment is mandatory for all parties before any prescription can be filled. Contact Bristol Myers Squibb at 1-888-423-5436 for enrollment assistance.

Medical Necessity Letter Components

Your oncologist should include these key elements in the medical necessity letter:

  1. Patient identification and diagnosis
  2. Complete treatment history with specific drugs, doses, and duration
  3. Evidence of progression on or within 60 days of last therapy
  4. Clinical rationale for Pomalyst as next appropriate treatment
  5. Proposed dosing regimen (typically 4 mg daily, days 1-21 of 28-day cycles)
  6. Combination therapy plan (usually with dexamethasone)
  7. Monitoring plan for side effects and efficacy

Submission Process

Step-by-Step Submission Guide

1. Verify Coverage (Day 1)

  • Check Humana's formulary using their drug search tool
  • Confirm Pomalyst requires prior authorization
  • Review any step therapy requirements

2. Complete REMS Enrollment (Days 1-3)

  • Prescriber completes REMS certification
  • Patient enrolls and signs Patient-Physician Agreement
  • Pharmacy confirms REMS participation

3. Gather Documentation (Days 2-5)

  • Collect all items from the preparation checklist
  • Request records from previous oncologists if needed
  • Obtain recent lab results and imaging

4. Submit Prior Authorization (Day 5-7)

  • Online: Use Humana's provider portal
  • Fax: Submit to 877-486-2621 (verify current number)
  • Phone: Call provider services for urgent cases

5. Track Submission (Ongoing)

  • Monitor portal for status updates
  • Follow up if no response within 5 business days
  • Be prepared to provide additional information

What to Include in Your Submission Packet

Document Type Required? Notes
Prior authorization form Yes Complete all sections
Medical necessity letter Yes From prescribing oncologist
Treatment history timeline Yes Include all prior MM therapies
REMS enrollment confirmation Yes All three parties certified
Recent lab results Yes Within 30 days preferred
Pathology/staging reports Recommended Support diagnosis
Insurance card copy Yes Front and back

Initial Outcome: Approval or Denial

Approval Timeline

  • Standard review: 3-14 business days
  • Expedited review: 24-72 hours (if urgent medical need)
  • Incomplete submission: Additional 5-10 days for clarification

Common Approval Conditions

When approved, Humana typically includes these requirements:

  • Prescription must be from an oncologist or hematologist
  • REMS program compliance ongoing
  • Quantity limits (usually 21 capsules per 28-day cycle)
  • Prior authorization valid for 6-12 months
  • Regular monitoring and progress reports required

Common Denial Reasons and Solutions

Denial Reason How to Address
Insufficient prior therapy documentation Submit complete treatment timeline with progression dates
REMS enrollment incomplete Confirm all three parties (prescriber, patient, pharmacy) are certified
Non-specialist prescriber Transfer prescription to oncologist/hematologist
Missing combination therapy plan Specify dexamethasone dosing in treatment plan
Lack of recent progression evidence Provide imaging or lab results showing disease advancement

Appeals Process in Washington

Important: Washington residents with Humana Medicare plans must follow federal Medicare appeals procedures, not the state's external review process.

Internal Appeals (Redetermination)

Timeline: File within 120 days of denial notice

How to Submit:

  1. Use Humana's appeals form from your member portal
  2. Include new supporting documentation
  3. Request peer-to-peer review with oncology specialist
  4. Submit via portal, fax, or mail as instructed

What to Include:

  • Original denial letter
  • Additional medical records addressing denial reason
  • Updated medical necessity letter
  • Peer-reviewed literature supporting treatment choice
  • Patient impact statement (optional but helpful)

Escalated Appeals Process

If your internal appeal is denied:

Level 2: Independent Review Entity (IRE)

  • Must request within 180 days of redetermination
  • Reviewed by independent medical professionals
  • Decision is binding on Humana
  • No cost to patient

Level 3 and Beyond:

  • Administrative Law Judge hearing
  • Medicare Appeals Council review
  • Federal District Court (if amount meets threshold)
Note: For urgent situations where waiting could jeopardize your health, request an expedited appeal at any level. Decisions must be made within 72 hours.

Washington-Specific Resources

While Medicare appeals follow federal rules, Washington residents have additional support:

  • SHIBA (Statewide Health Insurance Benefits Advisors): Free Medicare counseling at 1-800-562-6900
  • Washington State Office of Insurance Commissioner: Consumer advocacy and guidance
  • Medicare Rights Center: National organization with Washington-specific resources

Resolution and Approval Terms

Successful Appeal Outcomes

When appeals succeed, Humana typically provides:

  • Retroactive coverage from original prescription date
  • Clear approval duration (usually 6-12 months)
  • Renewal process outlined for continued coverage
  • Quantity and refill specifications

Ongoing Requirements

Once approved, maintain compliance by:

  • Keeping REMS certification current
  • Attending regular oncology appointments
  • Completing required lab monitoring
  • Documenting treatment response for renewals
  • Submitting renewal requests 30 days before expiration

What We'd Do Differently

Key Success Factors

Start Early: Begin prior authorization process 2-3 weeks before needed start date to allow for potential appeals.

Complete Documentation: Incomplete submissions are the leading cause of delays. Use our checklist to ensure nothing is missing.

REMS First: Complete REMS enrollment before submitting prior authorization to avoid automatic denials.

Specialist Prescriber: Ensure prescription comes from a board-certified oncologist or hematologist.

Track Everything: Keep copies of all submissions and maintain a timeline of communications.

Common Mistakes to Avoid

  • Submitting before REMS enrollment is complete
  • Missing specific progression documentation within 60 days
  • Incomplete prior therapy timeline
  • Generic medical necessity letters without patient-specific details
  • Waiting too long to appeal denials

Templates and Checklists

Prior Authorization Checklist

Print this checklist and check off each item before submission:

Patient Information:

  • Full name, DOB, member ID verified
  • Current contact information updated
  • Insurance card copied (front and back)

Medical Documentation:

  • Multiple myeloma diagnosis confirmed with ICD-10
  • Complete treatment history with dates
  • Progression documentation within 60 days
  • Recent lab results (within 30 days)
  • Medical necessity letter from oncologist

REMS Requirements:

  • Prescriber REMS certified
  • Patient REMS enrolled and agreement signed
  • Pharmacy REMS certified (if known)
  • Pregnancy testing current (if applicable)

Submission:

  • Prior authorization form complete
  • All supporting documents attached
  • Submission method confirmed (portal/fax)
  • Tracking number or confirmation received

Appeal Letter Template

When appealing a denial, use this structure:

[Date]
[Humana Appeals Department Address]

Re: Appeal for Prior Authorization Denial
Member: [Name]
Member ID: [Number]
Denial Date: [Date]
Reference Number: [If provided]

Dear Appeals Review Team,

I am appealing the denial of coverage for Pomalyst (pomalidomide) for my patient [Name] with multiple myeloma. The denial stated [specific reason from denial letter].

Patient Background:
[Brief summary of diagnosis and treatment history]

Medical Necessity:
[Detailed explanation addressing the specific denial reason]

Supporting Evidence:
[List of attached documents and relevant clinical guidelines]

Request:
I respectfully request reconsideration and approval of Pomalyst coverage based on the medical evidence provided.

Sincerely,
[Physician name and credentials]
[Contact information]

Frequently Asked Questions

Q: How long does Humana prior authorization take for Pomalyst in Washington? A: Standard reviews take 3-14 business days. Expedited reviews for urgent medical needs are completed within 24-72 hours.

Q: What if Pomalyst isn't on Humana's formulary? A: You can request a formulary exception with supporting medical documentation. The process is similar to prior authorization but requires additional justification for why covered alternatives aren't appropriate.

Q: Can I appeal a Humana denial in Washington state court? A: For Medicare plans, you must follow the federal Medicare appeals process. Washington's state external review process doesn't apply to Medicare Advantage or Part D plans.

Q: Does step therapy apply if I failed these drugs with a previous insurer? A: Yes, Humana accepts documentation of prior therapy failures from other insurers. Provide complete records showing lenalidomide and proteasome inhibitor trials and outcomes.

Q: What if I need to start treatment immediately? A: Request an expedited review if waiting would seriously jeopardize your health. Your oncologist must provide documentation supporting the urgent need.

Q: How much will Pomalyst cost with Humana coverage? A: Costs vary by plan. Most Medicare Part D plans place Pomalyst on the specialty tier with coinsurance typically 25-33% of the drug cost. Patient assistance programs may be available.

Q: What happens if my appeal is denied? A: You can request review by an Independent Review Entity (IRE) within 180 days. This is an external review by independent medical professionals, and their decision is binding on Humana.

Q: Can family members help with the appeals process? A: Yes, but they need written authorization from the patient to discuss medical information with Humana. Complete the appropriate HIPAA authorization forms.

From our advocates: We've seen many Pomalyst approvals succeed when families organize their documentation early and work closely with their oncology team. One strategy that often works is having the clinic coordinator call Humana's provider line to discuss the case before submitting—this can identify missing pieces upfront and speed the process.

About Counterforce Health

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, plan policies, and clinical notes to create targeted, evidence-backed responses. Our platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements and appeals processes, providing the specific documentation and procedural guidance needed to get prescription drugs approved.

For complex cases like Pomalyst approvals, having expert support can make the difference between a lengthy denial process and swift approval. Counterforce Health provides the specialized knowledge of payer-specific workflows and requirements that can streamline your path to coverage.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. Prior authorization requirements and appeals processes may change. Verify current procedures with Humana and consult Washington state insurance resources for the most up-to-date information.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.